As frustrated as most all of us are over the continuing drag on share price and our seemingly total inability to build on positive news with our share price, I would suggest a few thoughts:
-historically, we've had a totally incompetent management, even apparenly crooked one, but what's kept us just 'alive' is our science and 'hope';
-an objective assessment today of management changes and developing fundamentals, can only be seen as potentially very promising and different from the past, in that now a new foundation of competence and 'ruthless' focus is being laid to increase our share price;
-and the key element that has just 'destroyed' the positive effects of past good news, i.e, mammouth daily naked shorting/mm activity, will very soon be greatly eliminated as we uplist to a regulated / SEC monitored exchange; imo, I can't stress how crucial and important this development is, it's like being finally diagnosed as being cancer free, after years of anxiety, manipulation and total frustration;
- we've swallowed a lot of 'castor oil', if you will, to get to today's status, but we were very, very sick with a ridiculous number of outstanding shares and worse financial to move forward; that's been significantly positively changed and seen as the company starts to use the recently approved shares and shelf, their stated use for them being extremely positive and constructive and not to stay alive by any means, i.e., jv; clinical funding;capital requirement for uplisting, etc.;
-the recent positive approval developments in the European Union, seemingly insuring revenue as early as 2015 is huge; why?, because it's another early and first confirmation of commercialism and revenue for the company and the importance of that to wall street investors can't be overly stated as it's clearly the kind of 'stuff' the wall street hears and can relate to as the company now starts to take on the 'trappings' of a revenue generating company, a company to be followed, especially with all it's other scientific and/or clinical promises, for which the prestigious firms on wall street can now have some 'meat' to start assessing the market out there worldwide for the company's products now and to come and to project a target share price along with their analyses;
-this is why, imo, next tuesday's Piper Jafray 's prestigious conference has so much meaning and signals the beginning of a new phase of street recognition for OCAT, just by being there and what I'm assuming will be a soon to follow positive Piper Jafray coverage of OCAT.
I don't think I'm just posting another rah, rah 'silly' post, but one that even hard core posters, who want to finally see the 'beef' and hove some 'real' hope, will start to be impressed by.
Clearly time, imo, to continue to slowly add to one's position.
